A funny thing happened on the way to that $56,00-a-year Alzheimer’s drug: Payers are reluctant to pay, providers are reluctant to prescribe, and the price is coming down—at least for some patients.
With Medicare Undecided On Whether To Pay, Alzheimer’s Drug Maker Biogen Offers Free Doses
